Clinical Characteristics of Patients with Early or Late
Recurrence
In the Non-CF group, there was no significant difference in the baseline
patient characteristics, RF delivery time, and delivered RF energy
between the patients with and without ER (data not shown). On the other
hand in the CF group, the patients with ER included a higher proportion
of females, had a longer disease duration of PAF, higher pre-operative
plasma brain-type natriuretic peptide (BNP) level, longer RF delivery
time, and larger amount of RF delivery than those without ER (Female,
42.9% vs. 24.9%, p=0.001; disease duration of PAF, 41.2 ± 41.4 vs.
25.5 ± 24.4 months, p<0.001; BNP, 66.9 ± 58.7 vs. 43.5 ± 33.1
pg/ml, p<0.001; RF delivery time, 2185.4 ± 585.2 vs. 1963.4 ±
476.1 sec., p=0.017; amount of RF energy, 56349.7 ± 14616.6 vs. 52239.3
± 12397.5 J, p=0.070).
In the Non-CF group, the baseline patient characteristics was not
different between those with and those without LR (data not shown). In
the CF group, the disease duration of PAF was longer in patients with LR
than in those without LR (37.4 ± 34.6 vs. 30.3 ± 34.6 months, p =
0.005), and the prevalence of hypertension, the
CHA2DS2-VASc score, and pre-procedural
BNP level were higher in those with than in those without
LR(Hypertension, 66.2% vs. 49.8%, p=0.013;
CHA2DS2-VASc score, 2.2 ± 1.2 vs. 1.8 ± 1.2, p=0.042;
BNP, 62.2 ± 51.2 vs. 50.3 ± 45.2 pg/ml, p=0.026).